COLORADO SPRINGS, Colo., May 7, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) announced successful completion of the first live case using the TightRail™ Rotating Dilator Sheath performed by Charles Love, MD. On the heels of FDA clearance in April, the procedure represents a significant milestone as the company readies the TightRail tool for full launch later this month. "I was very pleased with how TightRail handled and tracked through the vasculature," said Dr. Love. "It easily passed through occlusions in the chronically occluded innominate vein and superior vena cava. These included areas that had some calcification. We easily and safely achieved the clinical goal. TightRail had no effect on the non-targeted leads in our experience." Dr. Love also accomplished one of the first lead extraction cases in the United State using the SightRail™ Manual Dilator Sheath. SightRail and TightRail represent Spectranetics' expansion of its portfolio to include manual extraction tools that complement the company's laser-based technology and provide a broader range of options for extracting physicians. According to Dr. Love, the additional inner sheath offset length that SightRail offers was especially helpful during the procedure. SightRail is also differentiated by visual indicators that show bevel orientation and tip alignment, supplementing fluoroscopy as a means of determining position and orientation. When Heart Rhythm Society's 35th Scientific Sessions convene in San Francisco this week, Dr. Love will present his first-case experiences and discuss next-generation mechanical extraction tools. His presentation is scheduled for Thursday, May 8, 9:45 a.m. in Spectranetics' Booth 2202. About Spectranetics Spectranetics develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The company's products are sold in more than 40 countries and are used to access and treat arterial blockages in the legs and heart, and to remove pacemaker and defibrillator cardiac leads.